thymine has been researched along with thiazolyl blue in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agostinis, P; Bouillon, R; Decraene, D; Degreef, H; Garmyn, M | 1 |
Emura, T; Fukushima, M; Kitazato, K; Murakami, Y; Nakagawa, F | 1 |
2 other study(ies) available for thymine and thiazolyl blue
Article | Year |
---|---|
Insulin-like growth factor-1-mediated AKT activation postpones the onset of ultraviolet B-induced apoptosis, providing more time for cyclobutane thymine dimer removal in primary human keratinocytes.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Apoptosis; Blotting, Southern; Blotting, Western; Cell Survival; Cells, Cultured; Coloring Agents; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Insulin-Like Growth Factor I; Keratinocytes; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidine Dimers; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymine; Time Factors; Ultraviolet Rays | 2002 |
A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells.
Topics: Animals; Antimetabolites; Antimetabolites, Antineoplastic; Cell Line, Tumor; Colorectal Neoplasms; Coloring Agents; Drug Combinations; Drug Resistance, Neoplasm; Fluorouracil; Globins; Humans; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Polymerase Chain Reaction; Pyrrolidines; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Thymidine Phosphorylase; Thymine; Trifluridine; Uracil | 2004 |